Company / Revenue
TriSalus Life Sciences, Inc. Revenue History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$29.4M
FY2025
5-year range
$12.4M / $29.4M
FY2023-FY2025
Trend
+59.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $12M to $29M over the past 2 years.
Based on SEC 10-K filings.
$29M in FY2025.
Improved from $12M to $29M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue increased 59.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.11 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.4M | +59.0% |
| FY2024 | $18.5M | +49.3% |
| FY2023 | $12.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026